Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-21

Clinical Trial Update: Colchicine in Vascular Inflammation Assessed With PET Imaging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing colchicine for vascular inflammation using PET imaging in atherosclerotic vascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Atherosclerotic Vascular Disease | Phase 2 | Status: COMPLETED